跳至主要内容
临床试验/ITMCTR2200005968
ITMCTR2200005968尚未招募1 期

Evaluation the therapeutic effect of Wenyang Jianpi Lishi Prescription combined with anti-VEGF drugs in the treatment of macular edema secondary to retinal vein occlusion due to spleen deficiency phlegm-dampness

Shenzhen Traditional Chinese Medicine Hospital0 个研究点开始时间: 待定最近更新:
适应症

试验速览

阶段
1 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional study

入排标准

年龄范围
18 至 80(—)
性别
All

入选标准

  • 18-80 years old RVO secondary macular edema, TCM syndromes conform to spleen deficiency phlegm-dampness type

排除标准

  • 1. RVO patients are younger than 18 years old or older than 80 years old;
  • 2. TCM syndromes of RVO patients do not conform to the type of spleen deficiency and phlegm-dampness;
  • 3. RVO patients have severe proliferative retinopathy or retinal detachment;
  • 4. Patients with RVO receive systemic or local (vitreous injection) hormones.

研究者

发起方
Shenzhen Traditional Chinese Medicine Hospital

相似试验